In contrast, classical murine or rat fibrosis models, such as CCl4 administration, surgical BDL and a steatohepatitis-inducing MCD diet, reliably provoke a defined inflammatory response within the injured liver [ 101].
We indeed demonstrated oxidative damage in the SN neurons in our rat model, and such damage was not observed in the Ndi1-expressing SN.
A rat model investigated such configuration of end-to-side nerve suture and showed that axonal regeneration through interpositional was bidirectional and preferentially directed towards the injured side clarifying the basis of clinical application [ 39].
First generation PD rat models employed neurotoxins such as 6-OHDA (6-hyroxydopamine) or MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) which acutely degenerate dopaminergic (DA) neurons in the substanatia nigra (SN), but do not result in significant α-syn pathology [ 10].
Despite similarities of the neuronal changes in TGR rat with several animal models such as the rd/rd, rds mouse and Royal College of Surgeons (RCS) rat, and reported vascular alterations, specific differences exist regarding the onset and developmental dynamics of the photoreceptor death.
Effects on candidate genes using such rat models have focused on genes known to be significant in the metabolic syndrome including peroxisomal proliferator-activated receptor (PPARα) and the glucocorticoid receptor (GR) [11], [13], [14].
The healing potential of mesenchymal and adipose-derived stem cells has recently been tested with rabbit and rat models and results of such experiments have provided more consistent results than PRP-based studies.
Recent studies have shown severe alterations of the enteric nervous system in rat models of experimental diabetes, such as a reduction in enteric neurons in the stomach [ 8], duodenum [ 9], ileum [ 10, 11], colon [ 12], cecum [ 13], and proximal colon [ 14], and alterations in the area of neuronal cellular bodies in the ileum [ 10, 11], colon [ 12], and cecum [ 13].
ROCK inhibitors have been widely used in animal models, such as rat and mice models, without causing major toxicity to the animals at efficient dosages [35], [56].
Routs such as sublingual, buccal, rectal and nasal can be difficult to establish in preclinical animal models, such as rat and mice.
